Published in Inorg Chem on October 21, 2013
Advancing biomedical imaging. Proc Natl Acad Sci U S A (2015) 0.91
Pyrene-Capped CdSe@ZnS Nanoparticles as Sensitive Flexible Oxygen Sensors in Non-Aqueous Media. ChemistryOpen (2014) 0.80
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors. J Am Chem Soc (2015) 0.79
Ratiometric QD-FRET Sensing of Aqueous H2S in Vitro. Anal Chem (2016) 0.77
A methacrylate-based polymeric imidazole ligand yields quantum dots with low cytotoxicity and low nonspecific binding. J Colloid Interface Sci (2015) 0.75
A Barcoding Strategy Enabling Higher-Throughput Library Screening by Microscopy. ACS Synth Biol (2015) 0.75
On the origin of cancer cells. Science (1956) 49.55
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
Quantum dots for live cells, in vivo imaging, and diagnostics. Science (2005) 21.62
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
Semiconductor nanocrystals as fluorescent biological labels. Science (1998) 16.68
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
Angiogenesis in life, disease and medicine. Nature (2005) 15.36
Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21
Deep tissue two-photon microscopy. Nat Methods (2005) 14.95
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med (2003) 14.59
Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science (1998) 14.44
Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol (2003) 13.29
Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater (2005) 12.97
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res (1989) 12.85
Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov (2007) 11.46
Fluorescence spectroscopy of single biomolecules. Science (1999) 10.67
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med (2001) 10.37
In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science (2002) 8.80
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 8.28
Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl (2009) 8.15
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol (2002) 7.92
Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science (2003) 7.33
Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science (2003) 6.92
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell (2003) 6.59
Hypoxia-inducible factors, stem cells, and cancer. Cell (2007) 5.96
Multiphoton fluorescence excitation: new spectral windows for biological nonlinear microscopy. Proc Natl Acad Sci U S A (1996) 5.78
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov (2011) 5.59
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell (2010) 4.98
Signaling Recognition Events with Fluorescent Sensors and Switches. Chem Rev (1997) 4.65
Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater (2003) 4.19
Multiphoton microscopy in life sciences. J Microsc (2000) 4.12
Single-molecule fluorescence spectroscopy of enzyme conformational dynamics and cleavage mechanism. Proc Natl Acad Sci U S A (1999) 4.05
Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer (2002) 3.96
Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93
Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res (1994) 3.84
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res (1992) 3.77
Electrochemical glucose biosensors. Chem Rev (2007) 3.67
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Single-pair fluorescence resonance energy transfer on freely diffusing molecules: observation of Förster distance dependence and subpopulations. Proc Natl Acad Sci U S A (1999) 3.61
Normal stem cells and cancer stem cells: the niche matters. Cancer Res (2006) 3.60
Long-term two-photon fluorescence imaging of mammalian embryos without compromising viability. Nat Biotechnol (1999) 3.44
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39
Design of organic molecules with large two-photon absorption cross sections. Science (1998) 3.27
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A (2012) 3.21
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med (2005) 3.19
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res (2006) 3.10
Compact biocompatible quantum dots functionalized for cellular imaging. J Am Chem Soc (2008) 2.92
The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res (1999) 2.91
Synthesis of compact multidentate ligands to prepare stable hydrophilic quantum dot fluorophores. J Am Chem Soc (2005) 2.71
Oligomeric ligands for luminescent and stable nanocrystal quantum dots. J Am Chem Soc (2003) 2.68
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
Bioorthogonal turn-on probes for imaging small molecules inside living cells. Angew Chem Int Ed Engl (2010) 2.57
HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46
Two-Photon Fluorescence Excitation Cross Sections of Biomolecular Probes from 690 to 960 nm. Appl Opt (1998) 2.31
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res (2002) 2.29
A ratiometric CdSe/ZnS nanocrystal pH sensor. J Am Chem Soc (2006) 2.27
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol (2003) 2.23
Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng (2011) 2.17
Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol (2004) 2.12
Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands. J Am Chem Soc (2007) 2.09
Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials (2005) 1.96
Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt (2002) 1.92
Fluorescence-based glucose sensors. Biosens Bioelectron (2004) 1.92
Noninvasive glucose sensing. Anal Chem (2005) 1.84
A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl (2010) 1.84
Development of a bioorthogonal and highly efficient conjugation method for quantum dots using tetrazine-norbornene cycloaddition. J Am Chem Soc (2010) 1.80
CdSe nanocrystal based chem-/bio- sensors. Chem Soc Rev (2007) 1.76
Quantum dot-based resonance energy transfer and its growing application in biology. Phys Chem Chem Phys (2008) 1.67
Two-photon absorption and the design of two-photon dyes. Angew Chem Int Ed Engl (2009) 1.65
Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand. J Am Chem Soc (2010) 1.60
Concise review: Emerging concepts in clinical targeting of cancer stem cells. Stem Cells (2011) 1.45
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ (2011) 1.40
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res (2001) 1.38
Submicrometer intracellular chemical optical fiber sensors. Science (1992) 1.26
Stabilization of inorganic nanocrystals by organic dendrons. J Am Chem Soc (2002) 1.25
Concanavalin A for in vivo glucose sensing: a biotoxicity review. Biosens Bioelectron (2006) 1.23
Fluorescent and colorimetric sensors for detection of lead, cadmium, and mercury ions. Chem Soc Rev (2011) 1.21
From diagnostics to therapy: prospects of quantum dots. Clin Biochem (2007) 1.20
Synthesis and properties of colloidal heteronanocrystals. Chem Soc Rev (2010) 1.16
Quantum-dot/dopamine bioconjugates function as redox coupled assemblies for in vitro and intracellular pH sensing. Nat Mater (2010) 1.15
Supramolecular optical chemosensors for organic analytes. Chem Soc Rev (2004) 1.12
Two steps forward in the treatment of colorectal cancer. N Engl J Med (2004) 1.12
Fluorescent PET (photoinduced electron transfer) sensors as potent analytical tools. Analyst (2009) 1.11
Multifunctional ligands based on dihydrolipoic acid and polyethylene glycol to promote biocompatibility of quantum dots. Nat Protoc (2009) 1.09
Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes. Adv Drug Deliv Rev (2011) 1.08
Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy. Photochem Photobiol (2006) 1.08
Luminescent CdSe/CdS core/shell nanocrystals in dendron boxes: superior chemical, photochemical and thermal stability. J Am Chem Soc (2003) 1.08
An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Int J Radiat Oncol Biol Phys (1997) 1.07
Optical colorimetric sensor strip for direct readout glucose measurement. Biosens Bioelectron (2009) 1.05
Two-photon absorbing nanocrystal sensors for ratiometric detection of oxygen. J Am Chem Soc (2009) 1.05
Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res (2000) 1.03
A quantum dot-based ratiometric pH sensor. Chem Commun (Camb) (2010) 1.03
Molecular mechanisms and clinical applications of angiogenesis. Nature (2011) 13.36
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell (2007) 12.52
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol (2003) 11.09
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell (2004) 8.78
Powering the planet: chemical challenges in solar energy utilization. Proc Natl Acad Sci U S A (2006) 8.15
Photodynamic therapy for cancer. Nat Rev Cancer (2003) 8.00
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res (2004) 5.65
Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev (2011) 5.64
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov (2011) 5.59
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med (2003) 5.50
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med (2009) 5.41
Lymphatic metastasis in the absence of functional intratumor lymphatics. Science (2002) 5.32
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol (2002) 5.04
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol (2012) 4.84
In situ formation of an oxygen-evolving catalyst in neutral water containing phosphate and Co2+. Science (2008) 4.63
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54
Tissue engineering: creation of long-lasting blood vessels. Nature (2004) 4.50
Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer? Chem Rev (2003) 4.45
Detection, stimulation, and inhibition of neuronal signals with high-density nanowire transistor arrays. Science (2006) 4.23
Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol (2009) 4.06
Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging (2003) 4.01
Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol (2006) 3.98
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med (2009) 3.85
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol (2013) 3.81
Comparing photosynthetic and photovoltaic efficiencies and recognizing the potential for improvement. Science (2011) 3.64
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Pathology: cancer cells compress intratumour vessels. Nature (2004) 3.60
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol (2010) 3.43
Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature (2002) 3.40
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A (2011) 3.34
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. Cancer Discov (2011) 3.34
Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J (2002) 3.25
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med (2005) 3.19
Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood (2008) 3.13
The role of nitric oxide in tumour progression. Nat Rev Cancer (2006) 3.08
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J Clin Oncol (2009) 3.02
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Res (2009) 3.00
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Compact biocompatible quantum dots functionalized for cellular imaging. J Am Chem Soc (2008) 2.92
Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol (2010) 2.85
Wireless solar water splitting using silicon-based semiconductors and earth-abundant catalysts. Science (2011) 2.76
Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. J Am Chem Soc (2004) 2.72
Response criteria for glioma. Nat Clin Pract Oncol (2008) 2.69
Engineering vascularized tissue. Nat Biotechnol (2005) 2.69
Monovalent, reduced-size quantum dots for imaging receptors on living cells. Nat Methods (2008) 2.68
Oligomeric ligands for luminescent and stable nanocrystal quantum dots. J Am Chem Soc (2003) 2.68
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A (2012) 2.66
Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol (2007) 2.65
Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J Am Chem Soc (2006) 2.65
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell (2013) 2.64
Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood (2007) 2.64
Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A (2010) 2.62
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc (2007) 2.59
Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol (2006) 2.58
Solar energy supply and storage for the legacy and nonlegacy worlds. Chem Rev (2010) 2.57
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation (2010) 2.53
Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg (2005) 2.52
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A (2012) 2.50
Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res (2006) 2.42
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res (2011) 2.40
CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res (2011) 2.39
Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett (2009) 2.37
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res (2006) 2.35
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun (2013) 2.31
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res (2002) 2.29
A ratiometric CdSe/ZnS nanocrystal pH sensor. J Am Chem Soc (2006) 2.27
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci U S A (2011) 2.27
Sentinel lymph node mapping with type-II quantum dots. Methods Mol Biol (2007) 2.26
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature (2004) 2.22
Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng (2011) 2.17
The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol (2011) 2.16
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A (2013) 2.14
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science (2009) 2.11
HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10
In vivo wide-area cellular imaging by side-view endomicroscopy. Nat Methods (2010) 2.10
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A (2006) 2.09
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res (2002) 2.09
Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol (2006) 1.99
Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood (2005) 1.98
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg (2005) 1.98
Proton-coupled electron transfer: the mechanistic underpinning for radical transport and catalysis in biology. Philos Trans R Soc Lond B Biol Sci (2006) 1.94
Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew Chem Int Ed Engl (2011) 1.93